Application of B-type natriuretic peptide in perioperative cardiac function assessment and volume management in elderly orthopedic patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400086372

Enrollment

Unknown

Registered

2024-06-30

Start date

2024-07-01

Completion date

Unknown

Last updated

2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly orthopedic patients

Interventions

hsTNI normal group:None

hsTNI abnormal group:None

Eligibility

Sex/Gender

All

Age

65 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) ASA ?-?; 2) Age?65 ; 3) Hip fracture patients admitted to the geriatric orthopedic ward after emergency admission assessment; 4) Patients who have signed informed consent for surgery and anaesthesia.

Exclusion criteria

Exclusion criteria: 1) Patients who do not agree to participate in the study by themselves or their legal representatives; 2) Patient with old hip fracture; 3) Patients with renal insufficiency; 4) Patients with atrial fibrillation, acute coronary syndrome, severe pericardial effusion, etc.

Design outcomes

Primary

Measure	Time frame
B type natriuretic peptide;	—

Secondary

Measure	Time frame
Total amount of vasoactive drugs used during the operation;Adverse event rate;	—

Countries

China

Contacts

Public ContactZhao Congcong

Beijing Jishuitan Hospital affiliated to Capital Medical University

zhaocongcong1991@163.com+86 157 1297 5752

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026